Robert D. Steiner
Profile
Robert D.
Steiner served as Chief Medical Officer at Opexa Therapeutics, Inc. and Acer Therapeutics, Inc. before obtaining undergraduate and doctorate degrees from the University of Wisconsin.
Former positions of Robert D. Steiner
Companies | Position | End |
---|---|---|
ACER THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2017-10-04 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Chief Tech/Sci/R&D Officer | - |
Training of Robert D. Steiner
University of Wisconsin | Doctorate Degree |
Experiences
Positions held
Linked companies
Private companies | 2 |
---|---|
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Stock Market
- Insiders
- Robert D. Steiner